Altimmune ALT
NASDAQ ALT
$2.97 +0.01 (+0.27%)
As of: Sep 29, 2026 · 3:59 PM EDT

Altimmune (ALT) Current Debt (2012 - 2014)

Updated

Altimmune (ALT) posted Current Debt of -$1.09 million for FY2014, compared with -$238,767 in FY2013.

Analysis

Altimmune (ALT) Current Debt (2012 - 2014) Analysis & Trends

  • Business Quant data shows ALT's Current Debt at -$238,767 in FY2013 and $1.33 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Altimmune 575.64 Mn 575.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 -1.09 Mn
Dec 31, 2013 1.09 Mn
Sep 30, 2013 -1.17 Mn
Jun 30, 2013 -161,090.00
Mar 31, 2013 -1,274.00
Dec 31, 2012 122,137.00
Mar 31, 2012 857,808.00
API Access

Altimmune Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=ALT&period=max&api_key=YOUR_API_KEY